KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Short-term Investments (2017 - 2025)

Bausch Health Companies' Short-term Investments history spans 13 years, with the latest figure at $16.0 million for Q4 2025.

  • For Q4 2025, Short-term Investments fell 20.0% year-over-year to $16.0 million; the TTM value through Dec 2025 reached $16.0 million, down 20.0%, while the annual FY2025 figure was $16.0 million, 20.0% down from the prior year.
  • Short-term Investments for Q4 2025 was $16.0 million at Bausch Health Companies, down from $32.0 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $1.2 billion in Q1 2021 and bottomed at $9.0 million in Q2 2023.
  • The 5-year median for Short-term Investments is $22.5 million (2024), against an average of $275.6 million.
  • The largest annual shift saw Short-term Investments crashed 99.09% in 2022 before it skyrocketed 211.11% in 2024.
  • A 5-year view of Short-term Investments shows it stood at $1.2 billion in 2021, then crashed by 97.78% to $27.0 million in 2022, then plummeted by 44.44% to $15.0 million in 2023, then soared by 33.33% to $20.0 million in 2024, then decreased by 20.0% to $16.0 million in 2025.
  • Per Business Quant, the three most recent readings for BHC's Short-term Investments are $16.0 million (Q4 2025), $32.0 million (Q3 2025), and $23.0 million (Q1 2025).